ORIC Pharmaceuticals, Inc. (ORIC) Income Annual - Discounting Cash Flows
ORIC
ORIC Pharmaceuticals, Inc.
ORIC (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
Report Filing 2025-11-13 2025-02-18 2024-03-11 2023-03-16 2022-03-21 2021-03-23 2019-12-31 2018-12-31 2017-12-31
Revenue 0 0 0 0 0 0 0 0 0
Cost of Revenue 0.304 1.11 1.03 0 0 0 1 0.9 0.9
Gross Profit -0.304 -1.11 -1.03 0 0 0 -1 -0.9 -0.9
Operating Expenses 147.7 141.8 109.7 91.77 78.87 74.19 27.57 21.47 21.64
Research & Development 115.9 114.1 85.17 61.68 56.86 60.76 22.84 19.03 19.13
Selling, General and Administrative 31.79 28.82 25.61 25.09 22.01 13.42 4.72 3.35 2.52
Other Operating Expenses 0 -1.11 -1.03 5 0 0 0 -0.9 0
Operating Income -148 -142.9 -110.8 -91.77 -78.87 -74.19 -28.57 -22.37 -22.54
Net Non-Operating Interest 0 0 10.08 0 0.141 0.306 1.4 0.775 0.251
Interest Income 0 0 10.08 2.65 0.141 0.306 1.4 0.775 0.251
Interest Expense 0 0 0 2.65 0 0 0 0 0
Equity & Other Income/(Expense) 12.75 15.05 0 2.65 0.015 0.177 0.289 0.233 0.261
Income Before Tax -135.3 -127.8 -100.7 -89.12 -78.72 -73.7 -26.88 -21.36 -22.03
Income Tax Expense 0 0 0 0 0 0 0 0 0
Income Attributable to Non-Controlling Interest 0 0 0 0 0 0 0 0 0
Net Income -135.3 -127.8 -100.7 -89.12 -78.72 -73.7 -26.88 -21.36 -22.03
Depreciation and Amortization 1.2 1.11 1.03 0.966 0.897 0.97 1 0.9 0.9
EBITDA -146.8 -141.8 -109.7 -90.8 -77.97 -73.22 -27.57 -21.47 -21.64
Earnings Per Share (EPS) -1.73 -1.83 -1.96 -2.25 -2.07 -3.36 -0.85 -1.12 -0.74
Diluted Earnings Per Share -1.73 -1.83 -1.96 -2.25 -2.07 -3.36 -0.85 -1.12 -0.74
Weighted Average Shares Outstanding 98.95 69.73 51.45 39.66 37.95 21.94 29.9 19.14 29.9
Diluted Weighted Average Shares Outstanding 98.95 69.73 51.45 39.66 37.95 21.94 29.9 19.14 29.9
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program